ADVERTISEMENT



Boehringer Ingelheim submits applications for approval of idarucizumab*, specific reversal agent to dabigatran etexilate (Pradaxa®), to EMA, FDA and Health Canada
SES: Satellite Plays Key Role in Future Networks
ZTE Achieves Explosive Sales Growth of 200 Percent in European 4G Core Network Market
GSMA Launches Humanitarian Connectivity Charter
Wipro Partners with Flytxt for Mobile Consumer Analytics Solutions
Seiko Instruments Releases New Automotive LDO Regulator Capable of 36V Input Voltage and 250mA Output Current
ZTE, Nuance, Audience, NXP and Sensory Discuss Voice Control at Smart Voice Alliance Seminar
Patton to Unveil New Session Border Controller with BRIs and Encrypted HD-Voice at CeBIT
OT to Showcase Its Embedded Secure Element (eSE) Based Mobile ID Solution at the Mobile World Congress 2015
ZTE Enables World Leading MOCN/CA/VoLTE-based Converged 4G Network for HKT
Abu Dhabi Police to Distribute 50 Thousand Awareness Brochures during GCC Traffic Week
MoI Child Protection Centre Takes Part in GCC Traffic Week
The 2015 AIMA Middle East Hedge Fund Summit to Convene Key Regional Investors with Global Industry Leaders
Saif bin Zayed Reviews Federal Demographic Structure Council Projects
Estonia Sets the Standard for a Digital Democracy
GSMA Presents 2015 Chairman’s Award to Jamal Ibrahim, Managing Director and CEO of Axiata Group
ZTE Doubled 4G Shipments and Global Market Share Exceeded 25 Percent in 2014
Visa and Samsung Bring Mobile Payments to the New Samsung Galaxy S6
ImmerVision Revolutionizes Smartphones and Tablets with Integrated 360-Degree Front-Facing Cameras
Khaled Juffali Industrial Company Ltd. is now a 100% Saudi Company

Most Popular Articles

Quick News

Boehringer Ingelheim submits applications...

March 3, 2015

  • First submission of an investigational specific reversal agent to a novel oral anticoagulant (NOAC) for regulatory approval
  • Boehringer Ingelheim pursues accelerated procedures with all three authorities1
  • In Phase I, idarucizumab has shown immediate, complete and sustained reversal of the anticoagulant effect of dabigatran (Pradaxa®)2

...

Continue Reading

SES: Satellite Plays Key Role in Future Networks...

March 3, 2015

Mobile World Congress 2015


Satellite has a key role to play in the architecture of future networks and the acceleration of digitization. This was one of the main conclusions of a keynote that Karim Michel Sabbagh, President and CEO of SES, delivered today at the GSMA Mobile World Congress in Barcelona. “Satellite"......

Continue Reading

ZTE Achieves Explosive Sales Growth of 200...

March 3, 2015

Mobile World Congress 2015

ZTE Corporation (0763.HK / 000063.SZ), a major international provider of telecommunications, enterprise and consumer technology solutions for the Mobile Internet, has today announced that"...

Continue Reading